Clinical Trial: NOPE37: Angiogenic Factors for Managing Term Preeclampsia

U.S., Sept. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07193680) titled 'NOPE37: Angiogenic Factors for Managing Term Preeclampsia' on July 21.

Brief Summary: This study tests the hypothesis that, in women with preeclampsia without severe features, delivery management based on sFlt-1/PlGF would reduce the rate of induction of labor without worsening the rate of progression to preeclampsia with severe features and other maternal complications.

Study Start Date: Oct. 20

Study Type: INTERVENTIONAL

Condition: Preeclampsia

Intervention: OTHER: Intervention arm: expectant management if sFlt-1/PlGF=37 weeks of gestation as in standard care for preeclampsia without severe features.

OTHER: Standard care: ...